fallopian tube cancer

AstraZeneca, Merck's Lynparza picks up new NICE recommendation
Fierce Pharma
Fri, 06/9/23 - 10:15 am
AstraZeneca
Merck
Lynparza
NICE
UK
ovarian cancer
fallopian tube cancer